Talis Biomedical Corporation (TLIS)
TLIS Stock Price Chart
Explore Talis Biomedical Corporation interactive price chart. Choose custom timeframes to analyze TLIS price movements and trends.
TLIS Company Profile
Discover essential business fundamentals and corporate details for Talis Biomedical Corporation (TLIS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
12 Feb 2021
Employees
99.00
Website
https://talisbio.comCEO
Rebecca Markovich
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.
TLIS Financial Timeline
Browse a chronological timeline of Talis Biomedical Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 18 Aug 2025
Earnings released on 6 May 2025
Earnings released on 17 Jan 2025
Earnings released on 27 Dec 2024
Earnings released on 19 Aug 2024
EPS came in at -$4.86 surpassing the estimated -$5.91 by +17.82%.
Earnings released on 8 May 2024
EPS came in at -$7.15 falling short of the estimated -$6.58 by -8.64%, while revenue for the quarter reached $73.00K , missing expectations by -87.44%.
Earnings released on 28 Mar 2024
EPS came in at -$7.39 falling short of the estimated -$6.68 by -10.67%, while revenue for the quarter reached $151.00K , missing expectations by -74.01%.
Earnings released on 14 Nov 2023
EPS came in at -$8.62 falling short of the estimated -$7.37 by -16.89%, while revenue for the quarter reached $76.00K , missing expectations by -86.92%.
Earnings released on 10 Aug 2023
EPS came in at -$8.27 falling short of the estimated -$0.73 by -1.03K%, while revenue for the quarter reached $48.00K , missing expectations by -54.29%.
Stock split effective on 6 Jul 2023
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 May 2023
EPS came in at -$9.90 falling short of the estimated -$0.73 by -1.26K%, while revenue for the quarter reached $137.00K , missing expectations by -45.20%.
Earnings released on 22 Mar 2023
EPS came in at -$14.99 falling short of the estimated -$11.39 by -31.61%, while revenue for the quarter reached $107.00K , missing expectations by -86.63%.
Earnings released on 3 Nov 2022
EPS came in at -$14.69 falling short of the estimated -$11.09 by -32.46%, while revenue for the quarter reached $730.00K , beating expectations by +102.78%.
Earnings released on 2 Aug 2022
EPS came in at -$15.14 falling short of the estimated -$12.29 by -23.19%, while revenue for the quarter reached $502.00K , missing expectations by -58.17%.
Earnings released on 10 May 2022
EPS came in at -$18.74 falling short of the estimated -$17.09 by -9.65%, while revenue for the quarter reached $2.31M , beating expectations by +493.08%.
Earnings released on 15 Mar 2022
EPS came in at -$1.26 surpassing the estimated -$1.28 by +1.56%, while revenue for the quarter reached -$218.00 , missing expectations by -100.02%.
Earnings released on 15 Nov 2021
EPS came in at -$22.34 surpassing the estimated -$25.04 by +10.78%, while revenue for the quarter reached $218.00 , missing expectations by -99.98%.
Earnings released on 10 Aug 2021
EPS came in at -$37.63 falling short of the estimated -$13.04 by -188.57%.
Earnings released on 11 May 2021
EPS came in at -$69.12 falling short of the estimated -$11.84 by -483.78%.
Earnings released on 30 Mar 2021
EPS came in at -$33.69 , while revenue for the quarter reached $10.94K .
Earnings released on 22 Jan 2021
EPS came in at -$101.53 .
TLIS Stock Performance
Access detailed TLIS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.